Disclosed are pyrimidine derivatives for use as sphingosine 1- phosphate 1 (S1P1) receptor agonists, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or diseases mediated by S1P1 receptors, particularly multiple sclerosis.
揭示了用作
鞘氨醇1-
磷酸1(S1P1)受体激动剂的
嘧啶衍
生物,以及它们的制备方法、含有它们的药物组合物以及它们在治疗由S1P1受体介导的疾病或病症,特别是多发性硬化症方面的用途。